Librela (bedinvetmab)

  PRESCRIPTION MEDICATION - RX Required

Librela is a breakthrough injectable solution designed to provide long-lasting pain relief for dogs suffering from osteoarthritis (OA). Featuring bedinvetmab, a monoclonal antibody that specifically targets and neutralizes nerve growth factor (NGF), Librela effectively reduces pain and inflammation, helping to improve your dog's quality of life. This monthly treatment is tailored to manage the chronic pain associated with OA, ensuring your canine companion can enjoy a more active and comfortable lifestyle.

Key Features:

• Long-Lasting Pain Relief: Offers up to one month of relief from osteoarthritis pain.
• Targeted Therapy: Utilizes bedinvetmab, a monoclonal antibody that specifically targets and inhibits NGF.
• Enhances Quality of Life: Reduces pain and inflammation, aiding dogs in regaining mobility and comfort.
• Convenient Monthly Injection: Simple, once-a-month administration by a veterinarian.
• Safe and Effective: Proven efficacy with minimal side effects.

Indications: Management of pain associated with osteoarthritis in dogs.

Dosage and Administration:

• Librela is administered as a subcutaneous injection once a month.
• Dosage is based on the dog's weight:

Ingredients:

Active Ingredient: Bedinvetmab

Caution:

• For veterinary use only.
• Not for use in dogs with known hypersensitivity to bedinvetmab.
• Use with caution in dogs with a history of severe allergic reactions.
• Always consult with your veterinarian before starting any new treatment.